Article thumbnail

Positive Result in the Early Passive Phase of the Tilt-table Test: A Predictor of Neurocardiogenic Syncope in Young Men

By Jae-Sun Uhm, Ho-Joong Youn, Woo-Baek Chung, Yun-Seok Choi, Chul-Soo Park, Yong-Seog Oh, Wook-Sung Chung, Kyung-Il Park and Tae-Suk Kim
Topics: Original Article
Publisher: The Korean Association of Internal Medicine
OAI identifier: oai:pubmedcentral.nih.gov:3295990
Provided by: PubMed Central

Suggested articles

Citations

  1. Components of clinical trials for vasovagal syncope.
  2. (1999). Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
  3. Epidemiology of reflex syncope.
  4. Head-up tilt test in subjects with no history of syncope or presyncope.
  5. Incidence and prognosis of syncope.
  6. Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing.
  7. Long-term outcome of patients with vasovagal syncope.
  8. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing.
  9. (1999). methodology, and classification of results of tilt-table testing.
  10. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.
  11. Neurally mediated syncope and arrhythmias: a study of syncopal patients using the head-up tilt test.
  12. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge.
  13. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.
  14. Predicting recurrence of vasovagal syncope: a simple risk score for the clinical routine.
  15. Prediction of headup tilt test result: is it possible? Pacing Clin Electrophysiol
  16. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
  17. Prognosis for neurocardiogenic syncope 65 http://dx.doi.org/10.3904/kjim.2012.27.1.60 http://www.kjim.or.kr Long-term follow-up of children and adolescents with syncope; predictor of syncope recurrence.
  18. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope.
  19. Recurrence of neurocardiogenic syncope without pharmacologic interventions.
  20. (1996). Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation
  21. (1996). Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope.
  22. (1997). Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope.
  23. The Italian Protocol’: a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope.
  24. (1994). The usefulness of headup tilt test in the diagnosis of syncope of unknown origin and clinical characteristics of the patients with vasovagal syncope.
  25. Usefulness of physical maneuvers for prevention of vasovagal syncope.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.